Compare BioNTech SE - ADR (BNTX) vs Charter Communications Inc (CHTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Charter Communications Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Charter Communications Inc trades at $156.98 (market cap $18.81B). The key difference: BioNTech SE - ADR is the larger of the two by market cap. Which is the better fit depends on your goals.
| BNTX | CHTR | |
|---|---|---|
Market Cap | $23.31B | $18.81B |
Sector | Health | Media |
52-Week High | $119.34 | $282.74 |
52-Week Low | $83.89 | $123.31 |
Enterprise Value | $6.60B | $115.01B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Charter Communications Inc
Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 54 million U.S. homes and businesses, around 40% of the country. Across this footprint, Charter serves 29 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest U.S. cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (long-term local rights to Los Angeles Lakers games), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1.
Read more on CHTR →
